Koninklijke Philips (PHG) Free Cash Flow Growth (3y) (2012 - 2026)
Koninklijke Philips (PHG) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 9.23% |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 16.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.76% |
| Mar 31, 2026 | -0.27% |
| Dec 31, 2025 | 91.19% |
| Sep 30, 2025 | 104.95% |
| Jun 30, 2025 | 50.25% |
| Mar 31, 2025 | -82.67% |
| Dec 31, 2024 | 17.64% |
| Sep 30, 2024 | 2.54% |
| Jun 30, 2024 | -48.13% |
| Mar 31, 2024 | -29.45% |
| Dec 31, 2023 | -2.12% |
| Sep 30, 2023 | -8.74% |
| Jun 30, 2023 | -24.50% |
| Mar 31, 2023 | -9.54% |
| Dec 31, 2022 | -53.90% |
| Sep 30, 2022 | -29.52% |
| Jun 30, 2022 | -36.35% |
| Mar 31, 2022 | -46.42% |
| Dec 31, 2021 | -18.77% |
| Sep 30, 2021 | -7.86% |